Loading...
Tumor heterogeneity: evolution through space and time in EGFR mutant non small cell lung cancer patients
NSCLC patients with mutations in epidermal growth factor receptor (EGFR) gene have dramatic responses with the EGFR tyrosine kinase inhibitors (TKI) in the majority of patients. However, all patients will eventually present progression of disease because of both primary and acquired resistance to EG...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Pioneer Bioscience Publishing Company
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367601/ https://ncbi.nlm.nih.gov/pubmed/25806236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.03.09 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|